Respiratory Tract
Respiratory Tract - Related Videos
01:31
Anatomy of Respiratory System II: Lower Respiratory Tract
0 Views •
2025
The lower respiratory tract is anatomically composed of several vital structures, including the larynx, trachea, bronchial tree, alveoli, lungs, and pleurae. Each component has a specific function, and all are intricately connected to ensure efficient respiration. The Larynx It is located between the pharynx and the trachea, acts as a passageway for air, and hosts several critical structures, such as the epiglottis, vocal cords, and glottis. The epiglottis acts as a gateway, guiding food to the...
01:29
Microbiota of the Respiratory Tract
0 Views •
2026
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:29
Anatomy of Respiratory System I: Upper Respiratory Tract
0 Views •
2025
The upper respiratory tract plays a vital role in the respiratory system, comprising several structures that facilitate air intake and prepare air for the lungs. It also serves as the first line of defense against pathogens and particles. This tract includes the nose and nasal cavity, the oral cavity, the paranasal sinuses, and the pharynx, each with specific functions and features. Nose and nasal cavity The nose and nasal cavity represent the main external openings of the respiratory tract.
07:16
Rapid Point-of-Care Detection of Pathogens for Lower Respiratory Tract Infections in ICU Patients
0 Views •
2026
This protocol describes a fully integrated microfluidic chip-based LAMP method enabling point-of-care detection of 15 pathogens causing lower respiratory tract infections in ICU patients within one hour.
01:24
Physical Assessment of the Respiratory Tract II: Palpation
0 Views •
2024
Physical assessment of the respiratory tract is critical in identifying potential health issues. One key component of this assessment is palpation, a technique healthcare providers use to assess the body for abnormalities. This content explores the method of palpation in evaluating the respiratory tract, focusing on thoracic palpation and tactile fremitus. Thoracic Palpation Thoracic palpation detects tenderness, masses, lesions, respiratory excursions, and vocal fremitus. The nurse assesses...
FAQs
Airway structure and airflow help determine which respiratory regions an inhaled medicine can reach. Air moves through the nasal passages, bronchi, and smaller airways, so drug distribution depends on this connected path before the medicine contacts target tissues. These features are therefore important when selecting and developing inhalation approaches for localized respiratory treatment.
Mucus and coordinated ciliary movement can remove inhaled particles and other material from airway surfaces. This clearance process may influence how long a medicine remains near its intended respiratory target and whether it can dissolve there. Pharmacological evaluation must therefore consider clearance alongside airway structure when assessing inhaled drug delivery and expected effects.
Airway epithelial barriers influence how inhaled medicines interact with respiratory tissues after deposition. The medicine must reach the relevant surface and dissolve before producing an effect, while the barrier also helps shape whether effects remain local or become systemic. Understanding this interaction supports interpretation of drug performance and guides inhaled formulation development.
Evaluation should consider airway structure, airflow, epithelial barriers, dissolution, and mucociliary clearance. Together, these factors describe the path from inhalation to contact with target tissues and help explain variation in local or systemic effects. Researchers can use this framework when assessing inhalation devices and determining whether a medicine is likely to reach the intended respiratory region.
Knowledge of the respiratory tract supports the development and use of several inhaled medicine categories, including bronchodilators, corticosteroids, and antimicrobials. The same structural and clearance considerations help determine how these treatments reach respiratory tissues. This makes airway biology relevant both to medicines intended for local respiratory effects and to delivery approaches that may produce systemic effects.
The respiratory tract provides a route through which medicines can contact airway and lung tissues after inhalation. Pharmacology therefore examines how airways conduct particles, how epithelial barriers influence tissue access, and how mucus and cilia affect removal. This knowledge supports rational development and use of inhalation devices, particularly for treatments aimed at respiratory disease.